BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8977566)

  • 1. [Invasive carcinoma of the cervix in young women in Tunisia].
    Maalej M; Daoud J; Messaad J; Frikha H; Benna F; Hechiche M; Rahal K; Ben Youssef R; Ben Romdhane K; Ben Abdallah M
    Bull Cancer Radiother; 1996; 83(3):158-63. PubMed ID: 8977566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].
    Saint-Paul MT; Brémond A; Rochet Y
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):737-42. PubMed ID: 8308199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invasive cancer of the uterine cervix in young women: retrospective study of 236 cases].
    Fenton J; Chevret S; Asselain B; de La Rochefordière A; Mathieu G; Labib A; Durand JC; Salmon RJ
    Bull Cancer; 1990; 77(2):109-16. PubMed ID: 2317580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of the uterine cervix in young women. A retrospective study of 337 cases].
    Acharki A; Sahraoui S; Benider A; Tawfiq N; Jouhadi H; Bouras N; Samlali R; Kahlain A
    Bull Cancer; 1997 Apr; 84(4):373-8. PubMed ID: 9238160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B
    Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and treatment of cervical malignant tumor in young women].
    Zhang Y; Shen K; Gao JS; Wu M; Huang HF; Pan LY; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):391-5. PubMed ID: 12974080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cervical carcinoma in the T1b stage. Therapy, complications and prognosis].
    Liebenstein J; Noack EJ; Hettenbach A; Bauknecht H
    Zentralbl Gynakol; 1984; 106(3):160-9. PubMed ID: 6702346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.
    Chargui R; Damak T; Khomsi F; Ben Hassouna J; Chaieb W; Hechiche M; Gamoudi A; Boussen H; Benna F; Rahal K
    Am J Obstet Gynecol; 2006 Jan; 194(1):43-8. PubMed ID: 16389008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive cervix cancer stage I and II in women less than 35 years old].
    Moniez V; Bauer V; Plocoste V; Magnin G; Avril A
    Rev Fr Gynecol Obstet; 1990 May; 85(5):321-7. PubMed ID: 2197707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors in the treatment of carcinoma of the cervix uteri in IB-IIA stage. Retrospective study].
    Sacco M; Tessa M; Rampino M; Ragona R; Origlia C; Del Mastro E; Rotta P
    Radiol Med; 1997 Jun; 93(6):764-73. PubMed ID: 9411526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Ghoshal S; Kumar V; Kapoor R
    Radiother Oncol; 2006 May; 79(2):142-6. PubMed ID: 16677730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer: women aged 35 and younger compared to women aged 36 and older.
    Clark MA; Naahas W; Markert RJ; Dodson MG
    Am J Clin Oncol; 1991 Aug; 14(4):352-6. PubMed ID: 1862767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.